Inflammation of the Middle Ear (Otitis Media): Drug Therapy

Therapeutic targets

  • Elimination of the pathogens
  • Avoidance of complications

Therapy recommendations

Antibiotic administration can usually be omitted if:

  • Uncomplicated otitis media is present (see table below).
  • no complications are present, such as:
    • Immunodeficiency (immune deficiency).
    • Influenza (flu)
    • Cleft lip and palate
    • Severe underlying diseases
    • Cochlear implant wearer (hearing prosthesis)
  • A good control by the doctor within the first three days is secured

Antibiotic therapy versus wait-and-see therapy (for uncomplicated otitis media) (modified from).

Age Mild (unilateral, without otorrhea) Medium (bilateral, without otorrhea) Severe bilateral with severe symptoms (temperature > 39 °C during the past 48 h, persistent otalgia > 48 h) or otorrhea
<6 months Antibiotic therapy (AB therapy) for 10 days
6-24 months
  • Wait-and-see behaviorIf necessary after 48-72 h of AB therapy for 10 days.
  • AB therapy for 10 days
  • AB therapy for 10 days
2-5th year of life
  • Wait-and-see behaviorIf necessary, after 48-72 h of AB therapy for 10 days.
  • Wait-and-see behaviorIf necessary after 48-72 h AB therapy for 7 days.
  • AB therapy for 10 days
≥ 6 years of age
  • Wait-and-see behaviorIf necessary, after 48-72 h of AB therapy for 5-7 days.
  • Wait-and-see behaviorIf necessary after 48-72 h AB therapy for 5-7 days.
  • AB therapy for 10 days

Note: Antibiotic therapy shows the greatest benefit in children <2 years of age. Further notes

  • Ear drops are obsolete (no longer in use).
  • Nasal drops may possibly improve the ventilation of the middle ear (e.g., in concomitant rhinosinusitis/simultaneous inflammation of the nasal mucosa (“rhinitis”) and the mucosa of the paranasal sinuses (sinusitis)), but there is no proven efficacy on the healing process.
  • See also under “Further therapy”.

Antibiotic therapy including symptomatic therapy (antipyretics/drugs that have a fever-reducing effect: Paracetamol, first-line agent in children):

Caveat.

  • The U.S. Food and Drug Administration advises caution in prescribing the antibiotic clarithromycin in patients with preexisting cardiac conditions. Results of a 10-year follow-up after 2-week treatment with clarithromycin showed increased all-cause mortality (hazard ratio 1.10; 1.00-1.21), and the rate of cerebrovascular disease (hazard ratio 1.19; 1.02-1.38) was also increased.
  • Cefepime: With cefepime and creatinine clearance < 50 ml/min, there is a risk of encephalopathy (collective term for abnormal brain changes) with impaired consciousness, confusion, hallucinations, stupor (state of extreme mental and motor numbness), and coma; myoclonus (brief involuntary twitching of single muscles or muscle groups) and seizures (incl. Nonconvulsive status epilepticus/prolonged epileptic seizure) are possible.

Supplements (dietary supplements; vital substances)

Suitable supplements for natural defense should contain the following vital substances:

Note: The listed vital substances are not a substitute for drug therapy. Dietary supplements are intended to supplement the general diet in the particular life situation.